U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.
- ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen (NASDAQ:AMGN), announced an agreement under which Amgen will acquire the company for $52 per share in cash.
- Global Blood Therapeutics, Inc. (NASDAQ: GBT) gained 41.4% to close at $47.99 following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, citing people familiar with the matter, some large pharmaceutical companies are looking into a potential deal.
- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 23.2% to close at $13.74 after the company reported better-than-expected Q2 EPS and sales results. The company also announced the FDA has lifted its partial clinical hold on the BCX9930 program.
- PagSeguro Digital Ltd. (NYSE: PAGS) gained 22.9% to close at $15.03.
- TTM Technologies, Inc. (NASDAQ: TTMI) rose 22.4% to close at $16.53 following upbeat Q2 results.
- Altice USA, Inc. (NYSE: ATUS) surged 21.5% to close at $11.75 following strong quarterly sales.
- MercadoLibre , Inc. (NASDAQ: NASDAQ:MELI) rose 16.2% to close at $1,034.83 following better-than-expected quarterly results.
- Insmed Incorporated (NASDAQ: INSM) jumped 15.2% to close at $25.06 following narrower-than-expected Q2 loss.
- Arcosa, Inc. (NYSE: ACA) jumped 14.9% to close at $58.93 after reporting upbeat Q2 results.
- Ashford Inc. (NYSE: AINC) gained 14.5% to close at $16.00 following Q2 earnings.
- Advanced Drainage Systems, Inc. (NYSE: WMS) jumped 13.6% to close at $136.82 after the company reported better-than-expected Q1 EPS and sales results and issued FY23 sales guidance above estimates.
- Sprouts Farmers Market, Inc. (NASDAQ: SFM) gained 13.5% to settle at $30.83 following better-than-expected quarterly results.
- Rent-A-Center, Inc. (NASDAQ: RCII) climbed 13.3% to close at $28.82 following upbeat quarterly earnings.
- Gol Linhas Aéreas Inteligentes S.A. (NYSE: GOL) rose 13.2% to settle at $3.85 after the company reported preliminary traffic figures for July 2022.
- Joby Aviation, Inc. (NYSE: JOBY) gained 13% to settle at $6.96 following the appearance of the company's CEO at the White House air mobility and EVTOL summit on Wednesday.
- BeiGene, Ltd. (NASDAQ: BGNE) jumped 12.6% to close at $191.08 after the company reported Q2 sales results up year over year.
- EPAM Systems, Inc. (NYSE: EPAM) gained 12.3% to settle at $415.39 after the company reported better-than-expected Q2 EPS and sales results and issued Q3 sales growth guidance of 22%.
- Confluent, Inc. (NASDAQ: CFLT) jumped 11.4% to close at $32.34 after the company reported better-than-expected Q2 EPS and sales results. Additionally, multiple analysts raised their price target on the stock.
- Ceridian HCM Holding Inc. (NYSE: CDAY) gained 10.4% to close at $64.88 after multiple analysts raised their price target on the stock. The company late Wednesday also reported Q2 results.
- Coinbase (NASDAQ:COIN) Global, Inc. (NASDAQ: COIN) rose 10% to settle at $88.90 after the company announced a partnership with BlackRock (NYSE:BLK).
- Vertiv Holdings Co (NYSE: VRT) jumped 9.8% to close at $13.17 after the company reported better-than-expected Q2 sales results. Goldman Sachs (NYSE:GS) maintained a Buy rating on the stock and raised its price target from $15 to $17.
- Grab Holdings Limited (NASDAQ: GRAB) gained 9.7% to close at $3.62.
- Procore Technologies, Inc. (NASDAQ: PCOR) rose 9.5% to settle at $62.04 following Q2 results.
- Mirati Therapeutics, Inc. (NASDAQ: MRTX) gained 8.5% to close at $77.90 following strong quarterly results.
- Immunocore Holdings plc (NASDAQ: IMCR) jumped 8.3% to close at $50.05.
- ATI Inc. (NYSE: ATI) gained 8.1% to close at $27.40 after reporting strong quarterly results.
- Installed Building Products, Inc. (NYSE: IBP) rose 6.8% to close at $104.52 following Q2 results.
- Huntington Ingalls Industries, Inc. (NYSE: HII) gained 4.6% to close at $228.81 as the company reported a second-quarter sales and service revenue increase of 19.3% year-over-year to $2.662 billion, beating the consensus of $2.62 billion.
- Novo Nordisk (CSE:NOVOb) A/S (NYSE: NVO) gained 4.6% to close at $104.47. Novo Nordisk reported Q2 sales of DKK41.27 billion, +25% Y/Y (+15% on a constant currency basis).
Read at Benzinga